治疗自身免疫病药物研究进展

被引：89

作者：

张玲玲

魏伟

机构：

[1] 安徽医科大学临床药理研究所抗炎免疫药物教育部重点实验室安徽省高校抗炎免疫药物协同创新中心安徽省高校抗炎免疫药物创新团队

来源：

中国药理学通报 | 2019年 / 35卷 / 02期

关键词：

自身免疫病; 非甾体抗炎药; 缓解病情抗风湿药; 生物制剂; JAK抑制剂; 炎症免疫反应软调节;

D O I：

暂无

中图分类号：

R97 [药品];

学科分类号：

100403 [营养与食品卫生学];

摘要：

自身免疫病(类风湿关节炎、系统性红斑狼疮、炎症性肠病等)是一类以局部或全身性异常炎症免疫反应为特征的疾病。目前,治疗自身免疫病药物主要分为非甾体抗炎药、甾体抗炎药、改善病情抗风湿药(化学药物、天然药物以及生物制剂)等。随着对自身免疫病病理机制的深入阐明和新药物靶点的发现,靶向细胞因子、受体和信号分子的新型生物制剂获得较快发展。靶向JAK/STAT信号通路的多个小分子药物,近年来也被研发应用于临床。炎症免疫反应软调节药物是一类具有抗炎免疫调节作用、不良反应少的药物,该类药物将是治疗自身免疫病药物研发的新策略和主要方向之一。该文综述了治疗自身免疫病药物的研究进展。

引用

收藏

页码：149 / 156

页数：8

相关论文

共 19 条

[1]

炎症免疫反应软调节 [J].

魏伟 .

中国药理学通报, 2016, 32 (03) :297-303

[2]

Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future [J].

Carrascosa, Jose-Manuel ;

Jacobs, Ira ;

Petersel, Danielle ;

Strohal, Robert .

DERMATOLOGY AND THERAPY, 2018, 8 (02) :173-194

[3]

A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases [J].

Rubbert-Roth, Andrea ;

Furst, Daniel E. ;

Nebesky, Jan Michael ;

Jin, Angela ;

Berber, Erhan .

RHEUMATOLOGY AND THERAPY, 2018, 5 (01) :21-42

[4]

Scrum proteomic analysis of the anti-arthritic effects of sinomenine on rats with collagen-induced arthritis [J].

Qian, Xin ;

Zhao, Zhiming ;

Shang, Wei ;

Xu, Zhihan ;

Zhang, Beibei ;

Cai, Hui .

MOLECULAR MEDICINE REPORTS, 2018, 18 (01) :49-58

[5]

Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies [J].

Trentin, Francesca ;

Gatto, Mariele ;

Zen, Margherita ;

Maddalena, Larosa ;

Nalotto, Linda ;

Saccon, Francesca ;

Zanatta, Elisabetta ;

Iaccarino, Luca ;

Doria, Andrea .

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (02) :331-343

[6]

Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study [J].

Yoshikawa, Ayaka ;

Yoshida, Shuzo ;

Kimura, Yuko ;

Tokai, Nao ;

Fujiki, Yohei ;

Kotani, Takuya ;

Matsumura, Yoko ;

Takeuchi, Tohru ;

Makino, Shigeki .

MODERN RHEUMATOLOGY, 2018, 28 (02) :227-234

[7]

Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis? [J].

Baker, Kenneth F. ;

Isaacs, John D. .

ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (02) :175-187

[8]

Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways [J].

Molinelli, Elisa ;

Campanati, Anna ;

Brisigotti, Valerio ;

Offidani, Annamaria .

CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (12) :964-978

[9]

Improving B-cell depletion in systemic lupus erythematosus and rheumatoid arthritis [J].

Mota, Pedro ;

Reddy, Venkat ;

Isenberg, David .

EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (07) :667-676

[10]

Abatacept: A Review in Rheumatoid Arthritis [J].

Blair, Hannah A. ;

Deeks, Emma D. .

DRUGS, 2017, 77 (11) :1221-1233